Table 1.
Potential advantages and disadvantages of neoadjuvant chemotherapy for colorectal liver metastases
Advantages
|
Disadvantages
|
(1) Conversion to resectability | (1) Chemotherapy-associated liver injury |
(2) Facilitate parenchymal-sparing or minimally invasive approach | (2) Local progression that precludes hepatic resection (rare) |
(3) Higher rates of negative margins | (3) Disappearing liver metastases |
(4) Improved patient selection for surgery | (4) Toxicity from chemotherapy |
(5) Improved rates of multimodality therapy | |
(6) Early treatment of micro-metastases | |
(7) Ability to assess response to therapy |